Drug intelligence / Profile preview

divalproex sodium

Development stage
Approved
Lead developer
Abbott
Modality
Small Molecules
Administration
Oral
01

Overview

Divalproex sodium is an anticonvulsant medication used primarily to treat seizure disorders (epilepsy), the manic phase of bipolar disorder, and to prevent migraine headaches. It is a stable coordination compound comprised of sodium valproate and valproic acid. The drug acts mainly by increasing brain levels of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter that helps reduce excessive electrical activity in the brain. Additional mechanisms may include blockade of voltage-gated sodium channels and inhibition of histone deacetylase enzymes. Divalproex sodium is available only by prescription and comes in several oral dosage forms[1][2][3][4][5][6].

Brand names
DepakoteDepakote ERDepakote Sprinkles
Other names
valproate semisodiumsodium valproate and valproic acid coordination compound
02

Targets

SSADH (Succinate-semialdehyde dehydrogenase)ABAT (4-aminobutyrate aminotransferase)HDAC1 (Histone Deacetylase 1)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on divalproex sodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on divalproex sodium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call